PDL BioPharma, Inc. Cost of Revenue

Cost of Revenue of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Cost of Revenue growth rates and interactive chart. Cost of revenue refers to the direct costs attributable to the production of the goods or supply of services by an entity. It is also commonly known as the “cost of goods sold (COGS)”. Cost of sales measures the cost of goods produced or services provided in a period by an entity. It includes the cost of the direct materials used in producing the goods, direct labor costs used to produce the good, along with any other direct costs associated with the production of goods. In case of services cost of sales includes the labor cost or salaries of the employees and other directly attributable costs. Cost of sales does not include indirect expenses such as distribution costs and marketing costs. It appears on the income statement and is deducted from the sales revenue for the calculation of gross profit (or gross margin).


Highlights and Quick Summary

  • Cost of Revenue for the quarter ending June 29, 2020 was $2.64 Million (a -7.73% decrease compared to previous quarter)
  • Year-over-year quarterly Cost of Revenue decreased by -82.45%
  • Annual Cost of Revenue for 2019 was $53.6 Million (a 10.65% increase from previous year)
  • Annual Cost of Revenue for 2018 was $48.5 Million (a 58.69% increase from previous year)
  • Annual Cost of Revenue for 2017 was $30.5 Million (a 651.22% increase from previous year)
  • Twelve month Cost of Revenue ending June 29, 2020 was $50.4 Million (a -4.35% decrease compared to previous quarter)
  • Twelve month trailing Cost of Revenue increased by 43.13% year-over-year
Trailing Cost of Revenue for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
$50.4 Million $52.7 Million $53.6 Million $35.2 Million
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Cost of Revenue of PDL BioPharma, Inc.

Most recent Cost of Revenueof PDLI including historical data for past 10 years.

Interactive Chart of Cost of Revenue of PDL BioPharma, Inc.

PDL BioPharma, Inc. Cost of Revenue for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $2.64 $2.86
2019 $29.86 $15.03 $4.93 $3.8 $53.62
2018 $11.44 $11.93 $14.52 $10.57 $48.46
2017 $17.91 $5.57 $4.52 $2.55 $30.54
2016 $4.07

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.